Both in Pharmaceuticals
Xenon Pharmaceuticals vs Acadia Pharmaceuticals
Over the past year XENE returned −4.8% and ACAD returned −5.5%; their daily moves had a correlation of 0.23.
XENE −4.8% ACAD −5.5%Growth of $1, one year, split-adjusted
| Metric | XENE | ACAD |
|---|---|---|
| Price | $39.14 | $21.14 |
| Market cap | $3.79B | $3.64B |
| Today | +2.38% | +2.75% |
| 1 month | +7.0% | +7.1% |
| 6 months | −33.2% | −1.6% |
| Year to date | −12.7% | −20.9% |
| 1 year | −4.8% | −5.5% |
| Revenue growth (YoY) | — | +16.4% |
| Gross margin | — | 90.8% |
| Net margin | — | 10.2% |
| P/E (TTM) | — | 9.6× |
| Price / sales | — | 3.2× |
| Net cash | $930.7M | $956.5M |
| Dividend yield | — | — |
| Volatility (60d) | 82.6% | 44.3% |
| Short % of float | 8.1% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).